Like all therapies, the wearable cardioverter defibrillator is most effective when used as prescribed, but this requires continuous adherence for up to 90 days and constant attention towards the various device alarms that may become activated at any given moment. Developments are underway to improve the garments, monitors and overall patient experience, but adherence will likely limit the patient population who will actually benefit from this cumbersome device. In the meantime, it will remain up to the cardiologist to decide which patients are the most appropriate candidates to not only receive the LifeVest but also wear it. Read more. Follow Cardiology on Twitter using #CardiologyMag and get the full issue here.